Letter by Machado-Alba et al Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis".

作者信息

Machado-Alba Jorge Enrique, Arias-Jaramillo Daniel Ricardo, Gaviria-Mendoza Andrés

机构信息

Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A. Pereira, Colombia, South America.

出版信息

Stroke. 2017 Jun;48(6):e148. doi: 10.1161/STROKEAHA.117.017375. Epub 2017 Apr 28.

DOI:10.1161/STROKEAHA.117.017375

PMID:28455317

Abstract

摘要

相似文献

Letter by Machado-Alba et al Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis".

Stroke. 2017 Jun;48(6):e148. doi: 10.1161/STROKEAHA.117.017375. Epub 2017 Apr 28.

Response by Bai et al to Letter Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis".白等人对关于“利伐沙班与达比加群或华法林在心房颤动卒中预防的真实世界研究：系统评价和荟萃分析”一文的信函的回复

Stroke. 2017 Jun;48(6):e149. doi: 10.1161/STROKEAHA.117.017460. Epub 2017 Apr 28.

Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.真实世界环境中比较非维生素 K 拮抗剂口服抗凝药与维生素 K 拮抗剂预防心房颤动卒中：系统评价和荟萃分析。

Stroke. 2017 Sep;48(9):2494-2503. doi: 10.1161/STROKEAHA.117.017549. Epub 2017 Jul 17.

Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis.利伐沙班与达比加群或华法林在心房颤动卒中预防真实世界研究中的比较：系统评价和荟萃分析

Stroke. 2017 Apr;48(4):970-976. doi: 10.1161/STROKEAHA.116.016275. Epub 2017 Feb 17.

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.达比加群、利伐沙班和阿哌沙班与华法林相比治疗非瓣膜性心房颤动的有效性和安全性。

J Am Heart Assoc. 2016 Jun 13;5(6):e003725. doi: 10.1161/JAHA.116.003725.

Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.真实世界中阿哌沙班在房颤卒中预防中的应用：系统评价和荟萃分析。

Stroke. 2018 Jan;49(1):98-106. doi: 10.1161/STROKEAHA.117.018395. Epub 2017 Nov 22.

Meta-Analysis of Effectiveness and Safety of Oral Anticoagulants in Atrial Fibrillation With Focus on Apixaban.以阿哌沙班为重点的口服抗凝剂治疗心房颤动有效性和安全性的Meta分析

Am J Cardiol. 2017 Nov 1;120(9):1689-1695. doi: 10.1016/j.amjcard.2017.07.072. Epub 2017 Aug 1.

Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.非瓣膜性心房颤动且既往有卒中和短暂性脑缺血发作患者中应用阿哌沙班、达比加群和利伐沙班与华法林的有效性和安全性。

Stroke. 2017 Aug;48(8):2142-2149. doi: 10.1161/STROKEAHA.117.017474. Epub 2017 Jun 27.

Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.低剂量非维生素K拮抗剂口服抗凝药与华法林在房颤患者中的有效性和安全性：倾向评分加权的全国队列研究

BMJ. 2017 Feb 10;356:j510. doi: 10.1136/bmj.j510.

Comparison of the cost-effectiveness of new oral anticoagulants for the prevention of stroke and systemic embolism in atrial fibrillation in a UK setting.英国背景下新型口服抗凝剂预防心房颤动患者中风和全身性栓塞的成本效益比较。

Clin Ther. 2014 Dec 1;36(12):2015-2028.e2. doi: 10.1016/j.clinthera.2014.09.015. Epub 2014 Oct 23.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验